Cosmetic Use Of Botulinum Toxin In The Maxillofacial Region: A Case Report

The purpose of this article is to present the case of maxillofacial trauma patient with maxillary sinus fracture diagnosed with cone-beam computed tomography (CBCT) and to explore the applications of this technique in evaluating the maxillofacial region. A 23-year-old male patient attempted to our clinic who had an injury at midface with complaints of swelling, numbness. The patient was examined before in emergency center but any diagnosis was made about the maxillofacial trauma. The patient re-examined clinically and radiographically. A fracture on the frontal wall of maxillary sinus is determined with the aid of CBCT. The patient consulted with the department of maxillofacial surgery and it is decided that any surgical treatment was not necessary. The emerging technique CBCT would not be the primary choice of imaging maxillofacial trauma. Nevertheless, when advantages considered this imaging procedure could be the modality of choice according to the case.

Download Full-text

Poster 258 A Novel Approach to the Treatment of Stiff-Person-Syndrome with Botulinum Toxin: A Case Report

PM&R ◽

10.1016/j.pmrj.2016.07.431 ◽

2016 ◽

Vol 8 (9) ◽

pp. S244 ◽

Cited By ~ 1

Author(s):

Chirag D. Shah ◽

Daniel Bunzol

Keyword(s):

Case Report ◽

Botulinum Toxin ◽

Botulinum Toxin A ◽

Stiff Person Syndrome ◽

Toxin A ◽

Novel Approach

Download Full-text

Constraint-Induced Movement Therapy After Injection of Botulinum Toxin Type A for a Patient With Chronic Stroke: One-Year Follow-up Case Report

Physical Therapy ◽

10.2522/ptj.20140329 ◽

2015 ◽

Vol 95 (7) ◽

pp. 1039-1045 ◽

Cited By ~ 4

Author(s):

Satoru Amano ◽

Takashi Takebayashi ◽

Keisuke Hanada ◽

Atsushi Umeji ◽

Kohei Marumoto ◽

...

Keyword(s):

Case Report ◽

Botulinum Toxin ◽

Muscle Tone ◽

Botulinum Toxin Type A ◽

Type A ◽

Movement Therapy ◽

Chronic Stroke ◽

Constraint Induced Movement Therapy ◽

Arm Function

Background and Purpose Spasticity, an aspect of upper motor neuron syndrome, is a widespread problem in patients with stroke. To date, no study has reported the long-term (up to 1 year) outcomes of botulinum toxin (BTX) injection in combination with constraint-induced movement therapy in patients with chronic stroke. In this case report, the long-term (1 year) effects of the combination of BTX type A injection and constraint-induced movement therapy on spasticity and arm function in a patient with chronic stroke and arm paresis are described. Case Description The patient was a 66-year-old man who had had an infarction in the right posterior limb of the internal capsule 4 years before the intervention. At screening, the patient was not able to voluntarily extend his interphalangeal or metacarpophalangeal joints beyond the 10 degrees required for constraint-induced movement therapy. From 12 days after BTX type A injection, the patient received 5 hours of constraint-induced movement therapy for 10 weekdays. Outcomes All outcome measures (Modified Ashworth Scale, Fugl-Meyer Assessment, Action Research Arm Test, and amount of use scale of the Motor Activity Log) improved substantially over the 1-year period (before intervention to 1 year after intervention). Repeat BTX type A injections were not necessary because muscle tone and arm function did not worsen during the observation period. Discussion The improved arm function may have reflected improvements in volitional movements and coordination or speed of movements in the paretic arm as a result of a reduction in spasticity, a reduction of learned nonuse behaviors, or use-dependent plasticity after the combination of BTX type A injection and constraint-induced movement therapy. In addition, the possibility of an influence of the passage of time or the Hawthorne effect cannot be ruled out. If this approach proves useful in future controlled studies, it may reduce the rising medical costs of the treatment of stroke.

Download Full-text